Enlightening Session with Georges Rawadi, CEO at Celyad Oncology
The landscape of gene and cell therapies is undergoing a significant transformation as regulatory bodies across different countries are actively improving their practices, guidelines, and human resources to accommodate the surge of new product submissions. In a recent interview, Georges Rawadi, CEO at Celyad Oncology discussed with Muhammad Younis the